Beam Therapeutics Inc (BEAM)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2006 | 12-2005 | 09-2005 | 06-2005 | 03-2005 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 175,000 | 93,600 | 207,300 | 152,100 | 187,400 |
| Receivables | 1,151,000 | 1,115,600 | 1,114,000 | 1,219,800 | 1,114,900 |
| Inventories | 2,106,500 | 1,663,100 | 1,665,400 | 1,115,800 | 1,130,600 |
| Other current assets | 349,300 | 320,400 | 320,900 | 317,100 | 313,600 |
| TOTAL | $3,781,800 | $3,192,700 | $3,307,600 | $2,804,800 | $2,746,500 |
| Non-Current Assets | |||||
| PPE Net | 1,830,700 | 1,679,600 | 1,691,400 | 1,382,000 | 1,379,700 |
| Investments And Advances | 79,900 | 1,243,400 | 1,375,200 | 0 | 0 |
| Intangibles | 7,618,000 | 6,880,500 | 6,473,400 | 3,340,600 | 3,346,000 |
| Other Non-Current Assets | 312,700 | 205,300 | 301,000 | 455,100 | 504,300 |
| TOTAL | $9,841,300 | $10,008,800 | $9,841,000 | $5,177,700 | $5,230,000 |
| Total Assets | $13,623,100 | $13,201,500 | $13,148,600 | $7,982,500 | $7,976,500 |
| Liabilities | |||||
| Current Liabilities | |||||
| Short Term Debt | 297,100 | 296,900 | 200 | 300 | 300 |
| Accounts payable and accrued liabilities | 422,900 | 688,400 | 743,900 | 380,600 | 373,400 |
| Accrued Expenses | 887,500 | 995,500 | 709,200 | 702,600 | 589,900 |
| TOTAL | $2,736,600 | $2,817,900 | $2,250,500 | $1,861,300 | $1,984,700 |
| Non-Current Liabilities | |||||
| Long Term Debt | 5,110,800 | 4,889,900 | 5,389,300 | 1,238,400 | 1,237,400 |
| aiOther Non-Current Liabilities | 859,700 | 851,700 | 911,600 | 1,241,300 | 1,261,000 |
| TOTAL | $7,101,300 | $6,738,000 | $7,377,500 | $2,612,500 | $2,637,900 |
| Total Liabilities | $9,837,900 | $9,555,900 | $9,628,000 | $4,473,800 | $4,622,600 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 146,635 | 146,345 | 146,112 | 145,979 | 145,447 |
| Common Shares | 717,400 | 717,400 | 717,400 | 717,400 | 717,400 |
| Retained earnings | 6,010,700 | 5,890,200 | 5,761,900 | 5,782,900 | 5,630,800 |
| Other shareholders' equity | -27,600 | -15,800 | -9,900 | -26,500 | 7,400 |
| TOTAL | $3,785,200 | $3,645,600 | $3,520,600 | $3,508,700 | $3,353,900 |
| Total Liabilities And Equity | $13,623,100 | $13,201,500 | $13,148,600 | $7,982,500 | $7,976,500 |